The nation of Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential information.
This rejection was revealed after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesman has since stated that the US was demanding access to health data for scientific study and commercial purposes but was unwilling to share the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more dialogue to find a deal acceptable to both sides so the country's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related health funding agreement after concerns were raised about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government deals to boost transparency and accountability.
Based on statements, 16 nations in Africa have to date signed similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"In essence, our nation would provide the raw materials for medical research without any certainty that the final treatments would be available to our people if a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining structures previously set up through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This mechanism is designed to ensure that when a country provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how future collaboration could be arranged in a manner that honours the independence and dignity of both nations."
Health Experts Response
Medical experts said it recognised the government's concerns, but suggested that talks should continue considering a large portion of the nation's Aids initiatives were funded by external financing.
"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
The situation emphasises the complex tensions between accepting vital international aid and protecting national sovereignty in an increasingly interconnected world.